Broek Richard Van-Den, Director at Celldex, holds 0.00 shares in Phasebio Pharmaceuticals (Ticker: PHASQ), holds 8.50K shares in Celldex (Ticker: CLDX), holds ― shares in Pulse Biosciences (Ticker: PLSE).
What was Broek Richard Van-Den’s latest transaction?
Broek Richard Van-Den latest transaction was an Uninformative Buy of ―.
What was Broek Richard Van-Den's most profitable transaction?
Broek Richard Van-Den’s most profitable transaction was an Informative Sell of SDI stock on December 30, 2014. The return on the trade was 14.20%.
What is Broek Richard Van-Den's role in Celldex?
Broek Richard Van-Den's role in Celldex is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.